News

Anna Veiga, new IDIBELL Ombudsperson

The appointment coincides with the constitution of the Research Integrity Committee (CIR), chaired by the Ombudsperson and including different members of the IDIBELL research community, and the update of the “Guide to Good Practices in Research in Health Sciences”.

Leer más about Anna Veiga, new IDIBELL Ombudsperson

Successful participation in the International Papilloma Virus Congress (IPVC2020)

This 33rd edition, now virtual, has been organized by the professional team of the Cancer Epidemiology Research Program (IDIBELL-ICO) and by the IPVC.

Leer más about Successful participation in the International Papilloma Virus Congress (IPVC2020)

A mouse model was used to determine the personalized treatment for a cancer patient

A team from IDIBELL and ICO, using a mouse orthotopic model, conducted a real-time personalized oncology study to test the best therapeutic option to treat a type of relapse sarcoma.

Leer más about A mouse model was used to determine the personalized treatment for a cancer patient

Common immune characteristics found in lung metastases to target future treatments

Lung metastatic tumours have common immune properties, regardless of the origin of the primary tumour.
These results suggest new approximations and contemplate the development of new immunotherapy treatments.

Leer más about Common immune characteristics found in lung metastases to target future treatments

A clinical trial coordinated by IDIBELL validates a less aggressive surgery for lower rectal cancer

The study has been published by the JAMA Surgery journal, the most prestigious in the world in its field, and has been led by Dr Sebastiano Biondo, from IDIBELL and the Bellvitge University Hospital.

Leer más about A clinical trial coordinated by IDIBELL validates a less aggressive surgery for lower rectal cancer

The study of lysosomal function during cell division enables the identification of a new biomarker for chromosomal instability

By studying the role of lysosomes in mitosis, an IDIBELL and UB group discovers that alterations in the separation of chromosomes cause a detectable nucleus morphology once mitosis has finished. This morphology would be useful to identify cells that have chromosomal instability inherent in cancer cells.

Leer más about The study of lysosomal function during cell division enables the identification of a new biomarker for chromosomal instability

A study proposes a new approach for the identification of a syndrome of predisposition to childhood cancer

Patients with this syndrome have more mutations in the microsatellite regions of the genome. The detection of these mutations improves the diagnosis and therapeutic management of patients.

Leer más about A study proposes a new approach for the identification of a syndrome of predisposition to childhood cancer

The combination of four drugs at low doses is more effective and less toxic in the treatment of a lung cancer type

The study, published in the Nature Communications journal, and led by the Netherlands Cancer Institute (NKI), has had the collaboration of researchers from IDIBELL/ICO and HUB.
This study demonstrates the beneficial effect of treatment with a cocktail drug at low doses to block a single signaling pathway in a lung cancer type.

Leer más about The combination of four drugs at low doses is more effective and less toxic in the treatment of a lung cancer type
Scroll to Top